A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

NCT01784211 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: LY2605541
DRUG: Insulin Glargine

Sponsor

Eli Lilly and Company